Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Boiron SA (Boiron) is a pharmaceutical company. It develops, manufactures and commercializes homeopathic medicines. The company operates through two reportable business segments, namely, Non-proprietary homeopathic medicines, associated with precise therapeutic indications and dosage; and OTC specialties, no specific therapeutic indication or dosage. Its product portfolio comprises Camilia, Euphralia, Arnigel, Oscillococcinum, Sedatif PC, Homeoptic and Stodal.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Contents
Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents 2
Section 1 - About the Company 6 Boiron SA - Key Facts 6 Boiron SA - Key Employees 7 Boiron SA - Key Employee Biographies 8 Boiron SA - Major Products and Services 9 Boiron SA - History 10 Boiron SA - Company Statement 12 Boiron SA - Locations And Subsidiaries 13 Head Office 13 Other Locations and Subsidiaries 13 Section 2 - Company Analysis 15 Boiron SA - Business Description 15 Boiron SA - SWOT Analysis 16 SWOT Analysis - Overview 16 Boiron SA - Strengths 16 Strength - Advanced RandD Activities 16 Strength - Widespread Geographic Presence 16 Boiron SA - Weaknesses 16 Weakness - Legal Proceedings 16 Boiron SA - Opportunities 16 Opportunity - Changing Demographics 16 Opportunity - Market Potential: Homeopathy 17 Boiron SA - Threats 17 Threat - Prejudice Against Homeopathy 17 Threat - Uncertain RandD Outcomes 17 Boiron SA - Key Competitors 18 Section 3 - Company Financial Ratios 19 Financial Ratios - Capital Market Ratios 19 Financial Ratios - Annual Ratios 20 Performance Chart 22 Financial Performance 22 Financial Ratios - Interim Ratios 23 Financial Ratios - Ratio Charts 24 Section 4 - Company's Lifesciences Financial Deals and Alliances 25 Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25 Boiron SA, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26 Boiron SA, Recent Deals Summary 27 Section 5 - Appendix 28 Methodology 28 Ratio Definitions 28 About GlobalData 32 Contact Us 32 Disclaimer 32
List of Tables Boiron SA, Key Facts 6 Boiron SA, Key Employees 7 Boiron SA, Key Employee Biographies 8 Boiron SA, Major Products and Services 9 Boiron SA, History 10 Boiron SA, Subsidiaries 13 Boiron SA, Key Competitors 18 Boiron SA, Ratios based on current share price 19 Boiron SA, Annual Ratios 20 Boiron SA, Interim Ratios 23 Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25 Boiron SA, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26 Boiron SA, Recent Deals Summary 27 Currency Codes 28 Capital Market Ratios 28 Equity Ratios 29 Profitability Ratios 29 Cost Ratios 30 Liquidity Ratios 30 Leverage Ratios 31 Efficiency Ratios 31
List of Figures Boiron SA, Performance Chart (2009 - 2013) 22 Boiron SA, Ratio Charts 24 Boiron SA, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25 Boiron SA, Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 26